Medical Oncology
- ISSN:
- 1357-0560
1
h-index
4
Citations
13
Works
0.08
2-year mean citedness
Trust signals
1 of 3 signals presentIndependent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.
- DOAJNo datadoaj.org
- OAK listNo dataOAK
- Valid ISSNPresentISSN
This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.
Trends over time
Performance over time
Citation overview
Publications (bars) and citations (line) by year
- Publications
- Citations
Citation history
Publication history
h-index evolution
Cumulative h-index by year
Most-cited works
- Involving stemness factors to improve CAR T-cell-based cancer immunotherapy20231 citations
- Advancing the potential of nanoparticles for cancer detection and precision therapeutics20251 citations
- Exosomal RNAs and EZH2: unraveling the molecular dialogue driving tumor progression20251 citations
- Targeting platelet-tumor cell interactions: a novel approach to cancer therapy20251 citations
- Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy20240 citations
- siRNA-based strategies to combat drug resistance in gastric cancer20240 citations
- Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors20240 citations
- Lipid metabolism reprogramming in renal cell carcinomas20240 citations
- Annexin A2: regulating glioma's fate and a potential therapeutic target20250 citations
- From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis20250 citations